These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 21033217)

  • 1. Detection of colorectal neoplasm using promoter methylation of ITGA4, SFRP2, and p16 in stool samples: a preliminary report in Korean patients.
    Chang E; Park DI; Kim YJ; Kim BK; Park JH; Kim HJ; Cho YK; Sohn CI; Jeon WK; Kim BI; Kim HD; Kim DH; Kim YH
    Hepatogastroenterology; 2010; 57(101):720-7. PubMed ID: 21033217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined detection of plasma GATA5 and SFRP2 methylation is a valid noninvasive biomarker for colorectal cancer and adenomas.
    Zhang X; Song YF; Lu HN; Wang DP; Zhang XS; Huang SL; Sun BL; Huang ZG
    World J Gastroenterol; 2015 Mar; 21(9):2629-37. PubMed ID: 25759530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Value of combined detection of ITGA4 and SFRP2 gene methylation in stool DNA in diagnosis and prognostic evaluation of colorectal tumors].
    Jin H; Pang L; Li H; Xu M; Yan H; Li R
    Nan Fang Yi Ke Da Xue Xue Bao; 2021 Jun; 41(6):891-897. PubMed ID: 34238742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypermethylated SFRP2 gene in fecal DNA is a high potential biomarker for colorectal cancer noninvasive screening.
    Wang DR; Tang D
    World J Gastroenterol; 2008 Jan; 14(4):524-31. PubMed ID: 18203283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of combined detection of multigene mutation and SDC2/SFRP2 methylation in stool specimens for colorectal cancer early diagnosis.
    Lin J; Zhang L; Chen M; Chen J; Wu Y; Wang T; Lu Y; Ba Z; Cheng X; Xu R; Tian T; Sun A; Zhang T; Chen M
    Int J Colorectal Dis; 2022 Jun; 37(6):1231-1238. PubMed ID: 35499710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of promoter hypermethylation of Wnt antagonist genes in fecal samples for diagnosis of early colorectal cancer.
    Zhang H; Zhu YQ; Wu YQ; Zhang P; Qi J
    World J Gastroenterol; 2014 May; 20(20):6329-35. PubMed ID: 24876755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative analysis of PCR-based biomarker assay methods for colorectal polyp detection from fecal DNA.
    Ausch C; Kim YH; Tsuchiya KD; Dzieciatkowski S; Washington MK; Paraskeva C; Radich J; Grady WM
    Clin Chem; 2009 Aug; 55(8):1559-63. PubMed ID: 19541867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SFRP2 methylation in fecal DNA--a marker for colorectal polyps.
    Oberwalder M; Zitt M; Wöntner C; Fiegl H; Goebel G; Zitt M; Köhle O; Mühlmann G; Ofner D; Margreiter R; Müller HM
    Int J Colorectal Dis; 2008 Jan; 23(1):15-9. PubMed ID: 17639423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of aberrant methylation in fecal DNA as a molecular screening tool for colorectal cancer and precancerous lesions.
    Huang ZH; Li LH; Yang F; Wang JF
    World J Gastroenterol; 2007 Feb; 13(6):950-4. PubMed ID: 17352030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel method for early detection of colorectal cancer based on detection of methylation of two fragments of syndecan-2 (SDC2) in stool DNA.
    Ma L; Qin G; Gai F; Jiang Y; Huang Z; Yang H; Yao S; Du S; Cao Y
    BMC Gastroenterol; 2022 Apr; 22(1):191. PubMed ID: 35436855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel methylation panel for the early detection of colorectal tumors in stool DNA.
    Azuara D; Rodriguez-Moranta F; de Oca J; Soriano-Izquierdo A; Mora J; Guardiola J; Biondo S; Blanco I; Peinado MA; Moreno V; Esteller M; Capellá G
    Clin Colorectal Cancer; 2010 Jul; 9(3):168-76. PubMed ID: 20643622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of promoter methylation in stool: a novel method for the detection of colorectal cancer.
    Lenhard K; Bommer GT; Asutay S; Schauer R; Brabletz T; Göke B; Lamerz R; Kolligs FT
    Clin Gastroenterol Hepatol; 2005 Feb; 3(2):142-9. PubMed ID: 15704048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Robust performance of a novel stool DNA test of methylated SDC2 for colorectal cancer detection: a multicenter clinical study.
    Wang J; Liu S; Wang H; Zheng L; Zhou C; Li G; Huang R; Wang H; Li C; Fan X; Fu X; Wang X; Guo H; Guan J; Sun Y; Song X; Li Z; Mu D; Sun J; Liu X; Qi Y; Niu F; Chen C; Wu X; Wang X; Song X; Zou H
    Clin Epigenetics; 2020 Oct; 12(1):162. PubMed ID: 33126908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A systematic review and quantitative assessment of methylation biomarkers in fecal DNA and colorectal cancer and its precursor, colorectal adenoma.
    Liu R; Su X; Long Y; Zhou D; Zhang X; Ye Z; Ma J; Tang T; Wang F; He C
    Mutat Res Rev Mutat Res; 2019; 779():45-57. PubMed ID: 31097151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypermethylation of SFRP2 as a potential marker for stool-based detection of colorectal cancer and precancerous lesions.
    Huang Z; Li L; Wang J
    Dig Dis Sci; 2007 Sep; 52(9):2287-91. PubMed ID: 17410438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Accuracy of early detection of colorectal tumours by stool methylation markers: a meta-analysis.
    Zhang H; Qi J; Wu YQ; Zhang P; Jiang J; Wang QX; Zhu YQ
    World J Gastroenterol; 2014 Oct; 20(38):14040-50. PubMed ID: 25320544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stool methylation-specific polymerase chain reaction assay for the detection of colorectal neoplasia in Korean patients.
    Baek YH; Chang E; Kim YJ; Kim BK; Sohn JH; Park DI
    Dis Colon Rectum; 2009 Aug; 52(8):1452-9; discussion 1459-63. PubMed ID: 19617759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is methylation analysis of
    Park SK; Baek HL; Yu J; Kim JY; Yang HJ; Jung YS; Choi KY; Kim H; Kim HO; Jeong KU; Chun HK; Kim K; Park DI
    Intest Res; 2017 Oct; 15(4):495-501. PubMed ID: 29142517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stool-based DNA testing, a new noninvasive method for colorectal cancer screening, the first report from Iran.
    Abbaszadegan MR; Tavasoli A; Velayati A; Sima HR; Vosooghinia H; Farzadnia M; Asadzedeh H; Gholamin M; Dadkhah E; Aarabi A
    World J Gastroenterol; 2007 Mar; 13(10):1528-33. PubMed ID: 17461444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The variation trends of SFRP2 methylation of tissue, feces, and blood detection in colorectal cancer development.
    Sui C; Ma J; Chen Q; Yang Y
    Eur J Cancer Prev; 2016 Jul; 25(4):288-98. PubMed ID: 26258809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.